Showing 491-500 of 21412 results for "".
- Insurance Churn Linked to Worse Diabetes Control in Community Health Center Patientshttps://reachmd.com/news/insurance-churn-linked-to-worse-diabetes-control-in-community-health-center-patients/2486335/Insurance churn—defined as losing coverage for multiple medical visits—was associated with near-term worsening in diabetes measures among low-income adults receivin
- Immune Cells and Blood Metabolites: New Insights into Diabetic Nephropathyhttps://reachmd.com/news/immune-cells-and-blood-metabolites-new-insights-into-diabetic-nephropathy/2484993/Mendelian randomization links genetic variation in specific immune cells and circulating metabolites to diabetic nephropathy, identifying 17 immune-cell associations and 25 m
- Understanding Gestational Diabetes Management Through Patient Experiences: A Qualitative Insighthttps://reachmd.com/news/understanding-gestational-diabetes-management-through-patient-experiences-a-qualitative-insight/2484517/A recent qualitative study involving 32 women with gestational diabetes mapped experiences from diagnosis through postpartum and identified actionable gaps in care. These fin
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2474516/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://reachmd.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- New AI Tool Accurately Detects 6 Different Cancer Types on Whole-Body PET/CT Scanshttps://reachmd.com/news/new-ai-tool-accurately-detects-6-different-cancer-types-on-whole-body-petct-scans/2467008/June 10, 2024 Toronto, Ontario—A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. By automatically q
- Diabetes Distress Linked to Foot-Risk in Primary Carehttps://reachmd.com/news/diabetes-distress-linked-to-foot-risk-in-primary-care/2488402/Key Takeaways Among 1,563 adults with diabetes in Brazilian primary health care, 39.8% were classified as being at some risk for diabetes-related foot disease. Participants with a diabetes-related foot disease risk classification had higher diabetes-related distress
- Schizophrenia and Aging May Share a Common Biological Basis: Genetic Changes in 2 Types of Brain Cellshttps://reachmd.com/news/schizophrenia-and-aging-may-share-a-common-biological-basis-genetic-changes-in-2-types-of-brain-cells/2457448/Credit: Pixabay/CC0 Public Domain Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have uncovered a strikingly similar suite of changes in gene activity i
- 0/2-Hour i-STAT hs-cTnI Pathway Validated in U.S. EDshttps://reachmd.com/news/02-hour-i-stat-hs-ctni-pathway-validated-in-us-eds/2488557/Key Takeaways In a prospective multisite observational cohort at three U.S. emergency departments, 578 patients had complete 0/2-hour assessments, index myocardial infarction occurred in 7.4% (43/578), and the original i-STAT hs-cTnI pathway classified 54.8% (317/578) to rule
- Integrating Social Determinants and Therapeutic Innovations in Diabetes Managementhttps://reachmd.com/news/integrating-social-determinants-and-therapeutic-innovations-in-diabetes-management/2476032/Diabetes management is as much about understanding social contexts as it is about leveraging the latest medical advancements. Unpacking these layers is critical in shaping effective and equitable healthcare strategies. Social determinants like neighborhood deprivation exert a measura